Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
Aoki J, Mintz GS, Weissman NJ, Mandinov L, Grube E, Dawkins KD, Ellis SG, Greenberg J, Yu A, Mann JT, Cannon L, Cambier PA, Stone GW. Aoki J, et al. Among authors: mann jt. Am J Cardiol. 2008 Oct 15;102(8):1009-16. doi: 10.1016/j.amjcard.2008.05.051. Epub 2008 Jul 26. Am J Cardiol. 2008. PMID: 18929701 Clinical Trial.
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Kutcher M, Wong SC, Strickland W, Mooney M, Russell ME, Ellis SG, Stone GW. Weissman NJ, et al. Among authors: mann jt. J Am Coll Cardiol. 2005 Apr 19;45(8):1201-5. doi: 10.1016/j.jacc.2004.10.078. J Am Coll Cardiol. 2005. PMID: 15837249 Free article. Clinical Trial.
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ; TAXUS-IV Investigators. Pinto DS, et al. Among authors: mann jt. J Am Coll Cardiol. 2006 Jul 4;48(1):32-6. doi: 10.1016/j.jacc.2006.02.060. Epub 2006 Jun 9. J Am Coll Cardiol. 2006. PMID: 16814645 Free article. Clinical Trial.
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
Aoki J, Mintz GS, Weissman NJ, Mann JT, Cannon L, Greenberg J, Grube E, Masud AR, Koglin J, Mandinov L, Stone GW. Aoki J, et al. Among authors: mann jt. JACC Cardiovasc Interv. 2008 Apr;1(2):161-7. doi: 10.1016/j.jcin.2007.12.005. JACC Cardiovasc Interv. 2008. PMID: 19463294 Free article. Clinical Trial.
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. Stone GW, et al. Among authors: mann jt. N Engl J Med. 2004 Jan 15;350(3):221-31. doi: 10.1056/NEJMoa032441. N Engl J Med. 2004. PMID: 14724301 Free article. Clinical Trial.
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. Stone GW, et al. Among authors: mann jt. Circulation. 2004 Apr 27;109(16):1942-7. doi: 10.1161/01.CIR.0000127110.49192.72. Epub 2004 Apr 12. Circulation. 2004. PMID: 15078803 Clinical Trial.
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Ellis SG, et al. Among authors: mann jt. J Am Coll Cardiol. 2005 Apr 19;45(8):1193-200. doi: 10.1016/j.jacc.2004.11.063. J Am Coll Cardiol. 2005. PMID: 15837248 Free article. Clinical Trial.
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Stone GW, et al. Among authors: mann jt. JAMA. 2005 Sep 14;294(10):1215-23. doi: 10.1001/jama.294.10.1215. JAMA. 2005. PMID: 16160130 Clinical Trial.
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Gray WA, Yeung AC, Cutlip DE, Popma JJ, Fitzgerald PJ, Williams DO, Heuer H, O'Shaughnessy CD, Overlie PA, Mann JT, Cannon LA, Hermiller JB, Henry TD, Whitbourn R, Stuckey TD, Midei MG, Coe J, Schwartz LB. Gray WA, et al. Among authors: mann jt. Int J Cardiol. 2012 May 17;157(1):96-101. doi: 10.1016/j.ijcard.2011.05.061. Epub 2011 Jun 11. Int J Cardiol. 2012. PMID: 21658783 Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
39 results